(Q72217954)
Statements
Phase I clinical trial of taxotere administered as either a 2-hour or 6-hour intravenous infusion (English)
H Burris
R Irvin
J Kuhn
S Kalter
L Smith
D Shaffer
S Fields
G Weiss
J Eckardt
scientific article published on 01 May 1993